Hainan Poly Pharm announcement, on July 7, 2024, the company disclosed the 'Announcement on Receipt of the Notice of Case Filing from the China Securities Regulatory Commission and Related Risk Tips' on the designated information disclosure website of the China Securities Regulatory Commission, Chaoxin News. Currently, the investigation by the China Securities Regulatory Commission is still ongoing, and the company has not received conclusive opinions or decisions on the case investigation matters. There is a risk of the company's stocks being forcibly delisted due to major violations of the law.
普利制药：公司涉嫌信息披露违规正被中国证监会立案调查
Hainan Poly Pharm: The company is suspected of violating information disclosure regulations and is currently under investigation by the China Securities Regulatory Commission.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated